September 8, 2020 Comments Off on Patent delisted for Merck Sharp drug PREVYMIS Posted in: Uncategorized
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…
The post Patent delisted for Merck Sharp drug PREVYMIS appeared first on DrugP…
September 8, 2020 Comments Off on Patent delisted for Boehringer Ingelheim drug GLYXAMBI Posted in: Uncategorized
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are eleven patents…
The post Patent delisted for Boehringer Ingelheim drug GLYXAMBI ap…
